This marks KKR's latest investment in India's healthcare sector, following investments in Baby Memorial Hospital, Healthium, Infinx, Max Healthcare, JB, and Gland Pharma. With the development, Dr. BS ...

As part of the deal, KKR will purchase up to 54 per cent of HCG's equity from CVC Asia V at a price of INR 445 per share.

March 4 (Reuters) - KKR & Co (KKR.N), opens new tab said on Tuesday it was looking to raise $1.5 billion through an offering of mandatory convertible preferred stocks and will use part of the ...

KKR makes its investment from its Asia Fund IV ... a leading Indian medical devices company; Infinx, a tech-enabled healthcare revenue solutions provider; Max Healthcare, one of India’s largest ...

Notably, KKR is investing through its Asia Fund IV, strengthening its focus on India’s healthcare sector. Its past investments include Baby Memorial Hospital, Healthium, Infinx, Max Healthcare ...

Infinx, a provider of AI-powered solutions for patient access and revenue cycle management, has acquired MedReceivables Advisor (MRA), a leader in pathology billing and revenue cycle management for ...

KKR KKR-5.61%decrease; red down pointing triangle has secured a majority stake in Fuji Soft and plans to take the company private, just days after rival Bain Capital dropped out of a monthslong ...

Infinx, an AI-powered healthcare revenue cycle management provider, has acquired MedReceivables Advisor (MRA), a company specializing in pathology billing for hospital-based practices, according ...

This marks KKR's latest investment in India's healthcare sector, following investments in Baby Memorial Hospital, Healthium, Infinx, Max Healthcare, JB, and Gland Pharma. With the development ...

MUMBAI, India, February 23, 2025--(BUSINESS WIRE)--KKR, a leading global investment firm, and Healthcare Global Enterprises (BSE: 539787; NSE: HCG; "HCG"), a leading healthcare organization in ...